231 related articles for article (PubMed ID: 3535055)
1. Infection management during antileukemia treatment-induced granulocytopenia: the role for oral norfloxacin prophylaxis against infections arising from the gastrointestinal tract.
Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
Scand J Infect Dis Suppl; 1986; 48():66-78. PubMed ID: 3535055
[TBL] [Abstract][Full Text] [Related]
2. Systemic infection and colonization with and without prophylactic norfloxacin use over time in the granulocytopenic, acute leukemia patient.
Karp JE; Dick JD; Merz WG
Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S5-13. PubMed ID: 3127219
[TBL] [Abstract][Full Text] [Related]
3. Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial.
Karp JE; Merz WG; Hendricksen C; Laughon B; Redden T; Bamberger BJ; Bartlett JG; Saral R; Burke PJ
Ann Intern Med; 1987 Jan; 106(1):1-7. PubMed ID: 3538962
[TBL] [Abstract][Full Text] [Related]
4. Prevention of gram-negative bacterial infection in granulocytopenic patients: a randomized study comparing oral norfloxacin with gentamycin.
Nemet D; Kalenic S; Badanjak A; Bogdanic V; Davila N; Francetić I; Labar B
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():105. PubMed ID: 2697389
[No Abstract] [Full Text] [Related]
5. Prophylactic administration of oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemias.
Liso V; Specchia G; Pavone V; Pansini N; Capalbo S; Ostuni A; Mastria A; Colucci A; Costantino G
J Chemother; 1989 Jul; 1(4 Suppl):1297-9. PubMed ID: 16312873
[No Abstract] [Full Text] [Related]
6. [A comparison of nystatin with norfloxacin for prevention of infection after consolidation therapy in patients with acute leukemia or autologous bone marrow transplantation: a randomized study].
Sampi K; Maseki N; Hattori M
Gan To Kagaku Ryoho; 1992 Jun; 19(6):823-6. PubMed ID: 1605660
[TBL] [Abstract][Full Text] [Related]
7. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Ann Intern Med; 1991 Jul; 115(1):7-12. PubMed ID: 2048868
[TBL] [Abstract][Full Text] [Related]
8. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
[TBL] [Abstract][Full Text] [Related]
9. Norfloxacin versus cotrimoxazole for infection prophylaxis in granulocytopenic patients with acute leukemia. A prospective randomized study.
Orlandi E; Navarra A; Cruciani M; Caldera D; Morra E; Castagnola C; Concia E; Bernasconi C
Haematologica; 1990; 75(3):296-8. PubMed ID: 2227631
[TBL] [Abstract][Full Text] [Related]
10. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation.
Menichetti F; Felicini R; Bucaneve G; Aversa F; Greco M; Pasquarella C; Moretti MV; Del Favero A; Martelli MF
Bone Marrow Transplant; 1989 Sep; 4(5):489-92. PubMed ID: 2790326
[TBL] [Abstract][Full Text] [Related]
11. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia.
Maschmeyer G; Haralambie E; Gaus W; Kern W; Dekker AW; De Vries-Hospers HG; Sizoo W; König W; Gutzler F; Daenen S
Infection; 1988; 16(2):98-104. PubMed ID: 3286509
[TBL] [Abstract][Full Text] [Related]
13. Management of infectious complications of acute leukemia and antileukemia therapy.
Karp JE; Merz WG; Dick JD; Saral R; Burke PJ
Oncology (Williston Park); 1990 Jul; 4(7):45-53; discussion 53-4. PubMed ID: 2143941
[TBL] [Abstract][Full Text] [Related]
14. Manipulation of the oropharyngeal and intestinal microflora by norfloxacin: microbiological and clinical aspects.
Edlund C; Nord CE
Scand J Infect Dis Suppl; 1988; 56():14-21. PubMed ID: 3074461
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic prophylaxis in cancer patients: regimens of oral, nonabsorbable antibiotics for prevention of infection during induction of remission.
Bodey GP
Rev Infect Dis; 1981; 3 suppl():S259-68. PubMed ID: 6805066
[TBL] [Abstract][Full Text] [Related]
16. Chemoprophylaxis of bacterial infections in granulocytopenic cancer patients using norfloxacin.
Casali A; Verri C; Paoletti G; Tropea F; Modugno G; Frasca AM; Ameglio F; Tonachella R; Gallo Curcio C
Chemioterapia; 1988 Oct; 7(5):327-9. PubMed ID: 3066518
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
[TBL] [Abstract][Full Text] [Related]
18. Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy.
Wells WG; Woods GL; Jiang Q; Gesser RM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii67-74. PubMed ID: 15150185
[TBL] [Abstract][Full Text] [Related]
19. Norfloxacin versus parenteral therapy in the treatment of complicated urinary tract infections and resistant organisms.
Cherubin C; Stilwell S
Scand J Infect Dis Suppl; 1986; 48():32-7. PubMed ID: 3535053
[TBL] [Abstract][Full Text] [Related]
20. The tolerability profile of prophylactic norfloxacin in neutropenic patients.
Corrado ML; Struble WE; Hesney M
Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S29-33. PubMed ID: 3280325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
